The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review ; volume:37 ; number:7 ; day:22 ; month:5 ; year:2020 ; pages:3059-3082 ; date:7.2020
Advances in therapy ; 37, Heft 7 (22.5.2020), 3059-3082, 7.2020
- Creator
-
Rugo, Hope S.
Jacobs, Ira
Sharma, Shikhar
Scappaticci, Frank
Paul, Thomas A.
Jensen-Pergakes, Kristen
Malouf, Gabriel G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-020-01379-x
- URN
-
urn:nbn:de:101:1-2020082101120336886512
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rugo, Hope S.
- Jacobs, Ira
- Sharma, Shikhar
- Scappaticci, Frank
- Paul, Thomas A.
- Jensen-Pergakes, Kristen
- Malouf, Gabriel G.
- SpringerLink (Online service)
Other Objects (12)
Histone methyltransferase SETDB1 regulates fetal hematopoiesis
Assay development and inhibitor optimization for the histone lysine methyltransferase KMT9
Histone methyltransferase SMYD2: ubiquitous regulator of disease
Histone methyltransferase and drug resistance in cancers
The histone methyltransferase DOT1L is required for DNA damage recognition and repair
A somatic role for the histone methyltransferase Setdb1 in endogenous retrovirus silencing
Structural insights into a novel histone methyltransferase - KMT9
Histone H3 lysine 4 methyltransferase is required for facultative heterochromatin at specific loci
The promise of Immuno-oncology: implications for defining the value of cancer treatment
Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3
Functional characterization of histone modifications : survey of novel histone modifications reveals PCMT1 as a new histone methyltransferase
Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma
Histone methyltransferase SETDB1 regulates fetal hematopoiesis
Assay development and inhibitor optimization for the histone lysine methyltransferase KMT9
Histone methyltransferase SMYD2: ubiquitous regulator of disease
Histone methyltransferase and drug resistance in cancers
The histone methyltransferase DOT1L is required for DNA damage recognition and repair
A somatic role for the histone methyltransferase Setdb1 in endogenous retrovirus silencing
Structural insights into a novel histone methyltransferase - KMT9
Histone H3 lysine 4 methyltransferase is required for facultative heterochromatin at specific loci
The promise of Immuno-oncology: implications for defining the value of cancer treatment
Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3
Functional characterization of histone modifications : survey of novel histone modifications reveals PCMT1 as a new histone methyltransferase
Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma
Histone methyltransferase SETDB1 regulates fetal hematopoiesis
Assay development and inhibitor optimization for the histone lysine methyltransferase KMT9
Histone methyltransferase SMYD2: ubiquitous regulator of disease
Histone methyltransferase and drug resistance in cancers
The histone methyltransferase DOT1L is required for DNA damage recognition and repair
A somatic role for the histone methyltransferase Setdb1 in endogenous retrovirus silencing
Structural insights into a novel histone methyltransferase - KMT9
Histone H3 lysine 4 methyltransferase is required for facultative heterochromatin at specific loci
The promise of Immuno-oncology: implications for defining the value of cancer treatment
Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3
Functional characterization of histone modifications : survey of novel histone modifications reveals PCMT1 as a new histone methyltransferase